JP2024510739A5 - - Google Patents
Info
- Publication number
- JP2024510739A5 JP2024510739A5 JP2023555544A JP2023555544A JP2024510739A5 JP 2024510739 A5 JP2024510739 A5 JP 2024510739A5 JP 2023555544 A JP2023555544 A JP 2023555544A JP 2023555544 A JP2023555544 A JP 2023555544A JP 2024510739 A5 JP2024510739 A5 JP 2024510739A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- antigen
- tumor
- dysfunctional
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021900708 | 2021-03-11 | ||
| AU2021900708A AU2021900708A0 (en) | 2021-03-11 | Novel Cell Therapy System | |
| AU2021902565A AU2021902565A0 (en) | 2021-08-17 | Novel Cell Therapy System (2) | |
| AU2021902565 | 2021-08-17 | ||
| AU2021902830A AU2021902830A0 (en) | 2021-09-01 | Novel cell therapy system (3) | |
| AU2021902830 | 2021-09-01 | ||
| PCT/AU2022/050206 WO2022187906A1 (en) | 2021-03-11 | 2022-03-11 | Novel cell therapy system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510739A JP2024510739A (ja) | 2024-03-11 |
| JP2024510739A5 true JP2024510739A5 (https=) | 2025-02-26 |
Family
ID=83226079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555544A Pending JP2024510739A (ja) | 2021-03-11 | 2022-03-11 | 新規な細胞治療システム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250281611A1 (https=) |
| EP (1) | EP4304610A4 (https=) |
| JP (1) | JP2024510739A (https=) |
| AU (1) | AU2022233737A1 (https=) |
| CA (1) | CA3211323A1 (https=) |
| MX (1) | MX2023010646A (https=) |
| WO (1) | WO2022187906A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3240805T3 (fi) * | 2014-12-15 | 2025-02-17 | Univ California | Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori |
| BR112023020659A2 (pt) * | 2021-04-08 | 2023-12-05 | Biosceptre Aust Pty Ltd | Métodos para controlar a atividade de célula imune |
| US20240368282A1 (en) * | 2021-09-01 | 2024-11-07 | Biosceptre (Aust) Pty Ltd | Methods and compositions for stimulating immune activity |
| JP2025531675A (ja) * | 2022-09-14 | 2025-09-25 | バイオセプター （オースト） プロプライエタリー・リミテッド | 操作された免疫細胞の富化 |
| IL322368A (en) * | 2023-02-03 | 2025-09-01 | Genzyme Corp | HSC-specific antibody-conjugated lipid nanoparticles and their uses |
| AU2024232401A1 (en) * | 2023-03-08 | 2025-08-21 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors for binding to dysfunctional p2x 7 receptor |
| EP4735479A1 (en) * | 2023-06-30 | 2026-05-06 | Biosceptre (Aust) Pty Ltd | Molecules and methods for activating car t cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2467404B1 (en) * | 2009-08-20 | 2015-09-30 | Biosceptre International Limited | Anti p2x7 receptor antibodies and fragments thereof |
| WO2011075789A1 (en) * | 2009-12-24 | 2011-06-30 | Biosceptre International Limited | Antibodies to non-functional oligomeric p2x7 receptors |
| US12121539B2 (en) * | 2015-09-11 | 2024-10-22 | Biosceptre (Aust) Pty Ltd | Chimeric antigen receptors and uses thereof |
| EP3315511A1 (en) * | 2016-10-29 | 2018-05-02 | Miltenyi Biotec GmbH | Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens |
| CN112166193A (zh) * | 2018-05-21 | 2021-01-01 | 生物权威（英国）有限公司 | 具有经修饰的接头结构域的嵌合抗原受体及其用途 |
-
2022
- 2022-03-11 EP EP22765997.6A patent/EP4304610A4/en active Pending
- 2022-03-11 US US18/281,045 patent/US20250281611A1/en active Pending
- 2022-03-11 MX MX2023010646A patent/MX2023010646A/es unknown
- 2022-03-11 JP JP2023555544A patent/JP2024510739A/ja active Pending
- 2022-03-11 AU AU2022233737A patent/AU2022233737A1/en active Pending
- 2022-03-11 WO PCT/AU2022/050206 patent/WO2022187906A1/en not_active Ceased
- 2022-03-11 CA CA3211323A patent/CA3211323A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510739A5 (https=) | ||
| JP7140861B2 (ja) | ヘテロ二量体多重特異性抗体フォーマット | |
| JP2024532482A5 (https=) | ||
| JP2019514361A5 (https=) | ||
| JP2024023228A5 (https=) | ||
| JP2023518134A5 (https=) | ||
| JP2022510218A5 (https=) | ||
| RU2015144098A (ru) | Четырехвалентные биспецифические антитела | |
| RU2018142544A (ru) | Биспецифические связывающие белки и пути их применения | |
| JP2025142045A5 (https=) | ||
| JP2019116474A5 (https=) | ||
| JP2019513370A5 (https=) | ||
| JP2019525771A5 (https=) | ||
| CN109053899B (zh) | 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体 | |
| JP7854121B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| JP2017504578A5 (https=) | ||
| JP2023507729A5 (https=) | ||
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| JP2018528786A5 (https=) | ||
| JP2023550998A5 (https=) | ||
| JP2022505445A5 (https=) | ||
| CN115066274A (zh) | 三价结合分子 | |
| WO2018045034A1 (en) | Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain | |
| JP2024508808A5 (https=) | ||
| KR20220083667A (ko) | 압타머 기반의 다중특이 치료제 |